Status:
UNKNOWN
Gynaecological Gender-affirming Surgeries
Lead Sponsor:
Amsterdam UMC, location VUmc
Conditions:
Gender Dysphoria
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this prospective cohort study is to learn about the patient report outcomes after gynaecological gender-affirming surgeries (i.e. hysterectomy, tubectomy, colpectomy) among trans-masculine...
Eligibility Criteria
Inclusion
- assigned female at birth
- scheduled to undergo gynaecological gender-affirming surgery (i.e. hysterectomy, ovariectomy, tubectomy and/or colpectomy)
Exclusion
- age below 18 y/o
- surgery combined with other surgeries (e.g. urethroplasty, metoidioplasty)
Key Trial Info
Start Date :
September 2 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT06098781
Start Date
September 2 2022
End Date
June 1 2025
Last Update
November 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam UMC, Location VU Medical Center
Amsterdam, Netherlands